Search Results - "CHRETIEN, Y"

Refine Results
  1. 1

    Are cirrhotic patients awaiting liver transplantation protected against vaccine-preventable diseases? by Mazzola, A., Minh, M. Tran, Jauréguiberry, S., Bernard, D., Lebray, P., Chrétien, Y., Goumard, C., Calmus, Y., Conti, F.

    Published in Clinical microbiology and infection (01-07-2018)
    “…Cirrhotic patients are immunocompromised and have an increased risk of infection with higher morbidity and mortality. Few data are available regarding the…”
    Get full text
    Journal Article
  2. 2

    Testing treatment effects in unconfounded studies under model misspecification: Logistic regression, discretization, and their combination by Cangul, M. Z., Chretien, Y. R., Gutman, R., Rubin, D. B.

    Published in Statistics in medicine (10-09-2009)
    “…Logistic regression is commonly used to test for treatment effects in observational studies. If the distribution of a continuous covariate differs between…”
    Get full text
    Journal Article
  3. 3

    Endorectal Color Doppler Sonography and Endorectal MR Imaging Features of Nonpalpable Prostate Cancer: Correlation with Radical Prostatectomy Findings by Cornud, F, Hamida, K, Flam, T, Helenon, O, Chretien, Y, Thiounn, N, Correas, J. M, Casanova, J. M, Moreau, J. F

    Published in American journal of roentgenology (1976) (01-10-2000)
    “…The purpose of this study was to describe endorectal sonography and color Doppler sonography features of nonpalpable prostate cancer and to assess the value of…”
    Get full text
    Journal Article
  4. 4

    Ten‐year survival in ursodeoxycholic acid–treated patients with primary biliary cirrhosis by Poupon, Renée Eugénie, Bonnand, Anne‐Marie, Chrétien, Yves, Poupon, Raoul

    Published in Hepatology (Baltimore, Md.) (01-06-1999)
    “…Ursodeoxycholic acid (UDCA) treatment has been shown to increase survival without orthotopic liver transplantation (OLT) in patients with primary biliary…”
    Get full text
    Journal Article
  5. 5

    Unusual fat-containing tumors of the kidney: a diagnostic dilemma by Hélénon, O, Merran, S, Paraf, F, Melki, P, Correas, J M, Chrétien, Y, Moreau, J F

    Published in Radiographics (01-01-1997)
    “…Unusual fat-containing renal tumors in a series of 27 cases comprised five categories: atypical and complicated angiomyolipomas (AMLs) (n = 15), including AMLs…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Influence of HFE gene polymorphism on the progression and treatment of chronic hepatitis C by Lebray, P., Zylberberg, H., Hue, S., Poulet, B., Carnot, F., Martin, S., Chretien, Y., Pol, S., Caillat-Zuckman, S., Bréchot, C., Nalpas, B.

    Published in Journal of viral hepatitis (01-03-2004)
    “…We analysed liver histology findings in a large cohort of patients with chronic hepatitis C and in roughly half of them their response to interferon‐α‐based on…”
    Get full text
    Journal Article
  8. 8

    Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC by Gallou, C., Joly, D., Méjean, A., Staroz, F., Martin, N., Tarlet, G., Orfanelli, M.T., Bouvier, R., Droz, D., Chrétien, Y., Maréchal, J.M., Richard, S., Junien, C., Béroud, C.

    Published in Human mutation (1999)
    “…To investigate the nature of somatic von Hippel‐Lindau (VHL) mutations, we analyzed 173 primary sporadic human renal cell carcinomas for mutations of the VHL…”
    Get full text
    Journal Article
  9. 9

    Dormant liver metastases: an experimental study by Panis, Y, Ribeiro, J, Chrétien, Y, Nordlinger, B

    Published in British journal of surgery (01-03-1992)
    “…Experimental work was undertaken to evaluate whether intrahepatic recurrences, observed after resection of colorectal liver metastases in humans, could be due…”
    Get more information
    Journal Article
  10. 10

    Place of nephrectomy in patients with autosomal dominant polycystic kidney disease waiting for renal transplantation by Cohen, D, Timsit, M-O, Chrétien, Y, Thiounn, N, Vassiliu, V, Mamzer, M-F, Legendre, C, Méjean, A

    Published in Progrès en urologie (Paris) (01-11-2008)
    “…To define the indications, results and place of nephrectomy for autosomal dominant polycystic kidney disease (ADPKD) in relation to renal transplantation…”
    Get more information
    Journal Article
  11. 11

    HBV genotypic resistance to lamivudine in kidney recipients and hemodialyzed patients by FONTAINE, H, THIERS, V, CHRETIEN, Y, ZYLBERBERG, H, POUPON, R. E, BRECHOT, C, LEGENDRE, C, KREIS, H, POL, S

    Published in Transplantation (27-05-2000)
    “…Lamivudine is a potent inhibitor of human immunodeficiency virus reverse transcriptase and hepatitis B virus (HBV) DNA polymerase. Its overall efficiency is…”
    Get full text
    Journal Article
  12. 12

    Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study by Housset, M, Maulard, C, Chretien, Y, Dufour, B, Delanian, S, Huart, J, Colardelle, F, Brunel, P, Baillet, F

    Published in Journal of clinical oncology (01-11-1993)
    “…To improve the results obtained by cystectomy alone and to determine the possibilities of conservative treatment in invasive bladder cancer, we designed a…”
    Get more information
    Journal Article
  13. 13

    Risk factors for cirrhosis in patients with chronic hepatitis C virus infection: Results of a case‐control study by Serfaty, L, Chazouilleres, O, Poujol‐Robert, A, Morand‐Joubert, L, Dubois, C, Chretien, Y, Poupon, R E, Petit, J C, Poupon, R

    Published in Hepatology (Baltimore, Md.) (01-09-1997)
    “…The role of the viral genotype, especially genotype 1b, in the severity of liver injury induced by chronic hepatitis C virus (HCV) infection is unclear,…”
    Get full text
    Journal Article
  14. 14

    Color doppler-guided prostate biopsies in 591 patients with an elevated serum psa level: Impact on gleason score for nonpalpable lesions by Cornud, F., Belin, X., Piron, D., Chrétien, Y., Flam, T., Casanova, J.M., Hélénon, O., Méjean, A., Thiounn, N., Moreau, J.F.

    Published in Urology (Ridgewood, N.J.) (01-05-1997)
    “…To compare results of color Doppler-guided ultrasonography (CDUS) versus those of systematic biopsies in 591 patients with an elevated serum PSA level and to…”
    Get full text
    Journal Article
  15. 15

    Postoperative radiation therapy in 26 patients with invasive transitional cell carcinoma of the upper urinary tract: no impact on survival? by Maulard-Durdux, C, Dufour, B, Hennequin, C, Chrétien, Y, Vignes, B, Droz, D, Delanian, S, Housset, M

    Published in The Journal of urology (01-01-1996)
    “…To evaluate the role of adjuvant radiation therapy in invasive transitional cell carcinoma of the upper urinary tract, we retrospectively reviewed a series of…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision by Mejean, A, Vogt, B, Quazza, J E, Chretien, Y, Dufour, B

    Published in European urology (01-10-1999)
    “…We have reviewed our surgical experience to document intra- and postoperative mortality and morbidity in 656 patients with renal cell carcinoma who underwent…”
    Get more information
    Journal Article
  18. 18

    Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? by Poupon, R, Chrétien, Y, Poupon, R E, Ballet, F, Calmus, Y, Darnis, F

    Published in The Lancet (British edition) (11-04-1987)
    “…The effects of ursodeoxycholic acid (UDCA, 13-15 mg/kg body weight daily) were prospectively evaluated in fifteen patients with primary biliary cirrhosis…”
    Get more information
    Journal Article
  19. 19

    Renal involvement in von Hippel-Lindau disease by Chauveau, Dominique, Duvic, Christian, Chrétien, Yves, Paraf, François, Droz, Dominique, Melki, Philippe, Hélénon, Olivier, Richard, Stéphane, Grünfeld, Jean-Pierre

    Published in Kidney international (01-09-1996)
    “…Renal involvement in von Hippel-Lindau disease. Renal involvement in von Hippel-Lindau (VHL) disease has emerged as the most prevalent cause of death in this…”
    Get full text
    Journal Article
  20. 20

    Phase II study of the oral cyclophosphamide and oral etoposide combination in hormone‐refractory prostate carcinoma patients by Maulard‐Durdux, Catherine, Dufour, Bertrand, Hennequin, Christophe, Chrétien, Y., Delanian, Sylvie, Housset, Martin

    Published in Cancer (15-03-1996)
    “…BACKGROUND Hormonotherapy temporarily controls symptoms in 80% of patients with metastatic prostate carcinoma. Once progression occurs, no consensus exists on…”
    Get full text
    Journal Article